U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07667582) titled 'Predictors and Outcomes of Ventilated Hospital-acquired Pneumonia' on June 18.
Brief Summary: Hospital-acquired pneumonia (HAP) is defined as an infection of the pulmonary parenchyma that develops in patients admitted to hospital for more than 48 hours and that was not incubating at the time of admission. It represents one of the most common and serious nosocomial infections, associated with significant morbidity, prolonged hospitalisation, and increased mortality in critically ill patients.
The aetiology of HAP is primarily driven by micro-aspiration of bacteria colonising the oropharynx and upper gastrointestinal tract. Pathogen ...